Sign in
CompletedPhase 2/3

Insulin nasal spray to prevent delirium after cardiac surgery

Key facts

Who runs it
Radboud universitair medisch centrum Stichting
Where
Netherlands1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 2/3
People taking part
30 people enrolled
Started
29 Apr 2026
Ended
10 Aug 2026
Type of study
Interventional
Record updated
30 March 2026

Who can take part

Age
65 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Age ≥65 years
  • Planned surgical admission to the ICU of the Radboudumc following complex cardiac surgery with CPB. Complex surgery is defined as: combined procedures (e.g., multi-vessel CABG or single CABG + valve replace-ment/repair); or aortic surgery (ascending aorta, arch, or root) or repair of aortic dissection; or expected CPB duration ≥ 90 minutes, as estimated preoperatively
  • Able to receive intranasal spray (no obstructive nasal pathology precluding administration)
  • Informed consent from patient

Who cannot take part

  • Delirium or dementia present at baseline
  • Single-vessel CABG, single valve replacement/repair or off-pump cardiac surgery
  • Known allergy/hypersensitivity to insulin or formulation excipients
  • Contra-indication for nasal administration (severe nasal pathology, recent nasal/sinus sur-gery, active epistaxis, active rhinitis, obstruction of either one or both nostrils)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to assess the feasibility, tolerability, and preliminary exploratory efficacy of intranasal insulin to prevent delirium in ICU patients aged ≥65 years after complex elective cardiac surgery with cardiopulmonary bypass.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Intranasal insulin for the prevention of delirium in ICU patients undergoing elective cardiac surgery: a randomized, double blind, placebo controlled pilot trial (INSPIRE)
Record updated
30 March 2026